These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32530392)

  • 1. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.
    Mughal MS; Kaur IP; Patton CD; Mikhail NH; Vareechon C; Granet KM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):638-639. PubMed ID: 32530392
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
    Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Fridkin SK; Collins MH
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1664-1671. PubMed ID: 35156597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period.
    Fujita K; Kada S; Kanai O; Hata H; Odagaki T; Satoh-Asahara N; Tagami T; Yasoda A
    Front Public Health; 2020; 8():595348. PubMed ID: 33365297
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care.
    Posfay-Barbe KM; Andrey DO; Virzi J; Cohen P; Pigny F; Goncalves AR; Pinosch S; Lacroix L; Stringhini S; Kaiser L; Vuilleumier N; L'Huillier AG
    Clin Infect Dis; 2021 Apr; 72(7):e192-e195. PubMed ID: 33161427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.
    Shah VP; Hainy CM; Swift MD; Breeher LE; Theel ES; Sampathkumar P
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1532-1534. PubMed ID: 33213552
    [No Abstract]   [Full Text] [Related]  

  • 16. Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department.
    Gras-Valentí P; Chico-Sánchez P; Algado-Sellés N; Gimeno-Gascón MA; Mora-Muriel JG; Jiménez-Sepúlveda NJ; Gómez-Sotero IL; Montiel-Higuero I; Sánchez-Payá J; Rodríguez-Díaz JC; ;
    Enferm Infecc Microbiol Clin (Engl Ed); 2021; 39(7):319-325. PubMed ID: 34353507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during bronchoscopy in the intensive care unit.
    Saha BK; Chenna P
    Respirology; 2021 Oct; 26(10):910-913. PubMed ID: 34387393
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
    Herrmann BL
    MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.
    Delmas C; Plu-Bureau G; Canouï E; Mouthon L; Meritet JF
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1406-1408. PubMed ID: 33143811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.